Loading...

4D pharma plc

DDDD.LLSE
Healthcare
Biotechnology
£16.66
£0.80(5.04%)

4D pharma plc (DDDD.L) Stock Competitors & Peer Comparison

See (DDDD.L) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
DDDD.L£16.66+5.04%0N/AN/AN/A
0QW0.L£352.20-1.36%13.4B-31.93-£11.03N/A
0A8K.L£31.24+0.03%8.3B-53.04-£0.59N/A
0H22.L£44.54+0.00%2.7B-9.78-£4.56N/A
0RC7.L£84.70-18.94%2.3BN/AN/AN/A
0HI3.L£15.70-3.39%2.2B-14.87-£1.08N/A
ONT.L£199.50-2.21%1.9B-12.47-£0.16N/A
GNS.L£2,490.00-0.20%1.6B-415.00-£0.06+1.29%
0RC6.L£73.87+0.00%1.5B14.69£5.03+1.01%
0K1R.L£17.29-1.48%1.4B-3.37-£5.14N/A
Showing 1 to 10 of 76 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

DDDD.L vs 0QW0.L Comparison August 2025

DDDD.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DDDD.L stands at 0. In comparison, 0QW0.L has a market cap of 13.4B. Regarding current trading prices, DDDD.L is priced at £16.66, while 0QW0.L trades at £352.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DDDD.L currently has a P/E ratio of N/A, whereas 0QW0.L's P/E ratio is -31.93. In terms of profitability, DDDD.L's ROE is -1.06%, compared to 0QW0.L's ROE of +0.17%. Regarding short-term risk, Volatility data is not available for a full comparison. DDDD.L has daily volatility of N/A and 0QW0.L has daily volatility of 0.00.Check 0QW0.L's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;